Revance Therapeutics Inc (RVNC)
3.08
+0.01
(+0.33%)
USD |
NASDAQ |
Dec 20, 16:00
3.05
-0.03
(-0.97%)
After-Hours: 20:00
Revance Therapeutics Total Assets (Quarterly): 461.56M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | 726.50M |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Ligand Pharmaceuticals Inc | 954.87M |
| MEI Pharma Inc | 27.75M |
| Cellectar Biosciences Inc | 37.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 624.59M |
| Shareholders Equity (Quarterly) | -163.03M |
| Debt to Equity Ratio | -2.645 |
| Current Ratio | 4.119 |
| Net Debt Paydown Yield | -1.87% |